Suppr超能文献

用于B型主动脉夹层血管内治疗的PETTICOAT概念。

The PETTICOAT concept for endovascular treatment of type B aortic dissection.

作者信息

Bertoglio Luca, Rinaldi Enrico, Melissano Germano, Chiesa Roberto

机构信息

Division of Vascular Surgery, Vita-Salute University, Scientific Institute H. San Raffaele, Milan, Italy -

Division of Vascular Surgery, Vita-Salute University, Scientific Institute H. San Raffaele, Milan, Italy.

出版信息

J Cardiovasc Surg (Torino). 2019 Feb;60(1):91-99. doi: 10.23736/S0021-9509.17.09744-0. Epub 2017 Feb 9.

Abstract

INTRODUCTION

A systematic literature search on outcomes of the PETTICOAT technique was aimed at verifying the feasibility and safety of the procedure, comparing clinical outcomes with standard stent-grafting of the proximal entry tear as well as describing the possible benefits in terms of aortic remodeling.

EVIDENCE ACQUISITION

Potentially eligible papers were sought through a computerized search of MEDLINE and SCOPUS databases between January 2006 and June 2016. Key words used for potentially eligible studies were: "dissection," "bare stent," "thoracic," "endovascular," "PETTICOAT". Studies were considered for review on the basis of these criteria: including more than 5 cases, providing full information on the type of dissection treated and the onset of dissection as well as reporting clinical and technical outcomes.

EVIDENCE SYNTHESIS

The literature search identified 11 studies (4 prospective and one controlled) in which the PETTICOAT treatment was employed (439 cases) in type A (N.=40; 9.1%) and Type B (N.=399; 90.9%) dissection complicated by malperfusion in 48.4% of cases with different dissection onsets: acute in 295 cases (67.3%), subacute in 54 cases (12.3%) and chronic in 90 cases (20.5%). Due to the heterogeneity of the cohorts, only the perioperative results of 4 papers (143 patients) reporting a single stage PETTICOAT procedure for the treatment of acute (89 cases) or subacute (54 cases) type B dissection were pooled together. The pooled data demonstrated that the procedure is feasible and safe with an overall 30-day mortality rate of 4.9% and clinical success rate of 90.2%. Six out of 11 papers proposed a clinical comparison between TEVAR alone (TEVAR) and PETTICOAT in the same dissection setting with no clinical success differences reported at short-term. In terms of aortic remodeling 9 out of 11 papers reported the behavior of lumina after the procedure. All studies observed an early significant expansion of the true lumen expansion in the thoracic and abdominal aorta but when false lumen is taken into consideration, the data are more heterogeneous: both the thoracic and abdominal false lumen decreased in size significantly postoperatively due to the redistribution of the lumens but, at follow-up (6 studies), the FL continued to decrease in size in the stent-grafted area, while in the abdominal aorta remained stable with no shrinkage (4 studies) or increased (2 studies at 2 year follow-up).

CONCLUSIONS

Analysis of the literature data, not only does it demonstrate that the PETTICOAT technique is safe and feasible but also that it is able to enhance the effect of the proximal TEVAR improving the re-expansion of the true lumen of the distal thoraco-abdominal aorta possibly improving end-organ perfusion. However, since there is no evidence of improved short and mid-term survival as well as positive remodeling of the false lumen in the distal aorta, when compared to a simple proximal stent-grafting, a wide-spread use of the PETTICOAT technique is not justified and it should be limited to cases complicated by dynamic malperfusion as a bailout adjunctive tool.

摘要

引言

对PETTICOAT技术的结果进行系统文献检索,旨在验证该手术的可行性和安全性,将临床结果与近端入口撕裂的标准支架植入术进行比较,并描述其在主动脉重塑方面的可能益处。

证据收集

2006年1月至2016年6月期间,通过计算机检索MEDLINE和SCOPUS数据库,寻找可能符合条件的论文。用于可能符合条件研究的关键词为:“夹层”、“裸支架”、“胸段”、“血管内”、“PETTICOAT”。根据以下标准考虑纳入研究进行综述:包括超过5例病例,提供所治疗夹层类型和夹层发病情况的完整信息,以及报告临床和技术结果。

证据综合

文献检索确定了11项研究(4项前瞻性研究和1项对照研究),其中在A型(n = 40;9.1%)和B型(n = 399;90.9%)夹层中采用了PETTICOAT治疗,48.4%的病例合并灌注不良,不同夹层发病情况如下:急性295例(67.3%),亚急性54例(12.3%),慢性90例(20.5%)。由于队列的异质性,仅将4篇论文(143例患者)报告的单阶段PETTICOAT手术治疗急性(89例)或亚急性(54例)B型夹层的围手术期结果进行汇总。汇总数据表明该手术可行且安全,总体30天死亡率为4.9%,临床成功率为90.2%。11篇论文中有6篇在相同夹层情况下对单纯胸主动脉腔内修复术(TEVAR)和PETTICOAT进行了临床比较,短期未报告临床成功率差异。在主动脉重塑方面,11篇论文中有9篇报告了术后管腔情况。所有研究均观察到胸主动脉和腹主动脉真腔早期显著扩张,但考虑假腔时,数据更具异质性:由于管腔重新分布,胸主动脉和腹主动脉假腔术后大小均显著减小,但在随访时(6项研究),支架植入区域的假腔继续减小,而腹主动脉假腔保持稳定,无缩小(4项研究)或增大(2项2年随访研究)。

结论

对文献数据的分析表明,PETTICOAT技术不仅安全可行,而且能够增强近端TEVAR的效果,改善远端胸腹主动脉真腔的再扩张,可能改善终末器官灌注。然而,与单纯近端支架植入术相比,由于没有证据表明其能改善短期和中期生存率以及远端主动脉假腔的正向重塑,PETTICOAT技术的广泛应用不合理,应仅限于合并动态灌注不良的病例作为补救辅助工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验